Applied BioMath's blog

April 30, 2018

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic systems modeling, simulation, and analysis to de-risk drug research and development, today announces their upcoming participation at PEGS: The Essential Protein Engineering Summit being held April 30 - May 4, 2018 in Boston, MA. Applied BioMath is sponsoring, exhibiting, presenting a poster, and presenting two talks at the conference.

Wednesday, April 25, 2018

Monday, April 23, 2018

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic mathematical modeling, simulation, and analysis to de-risk therapeutic research and development, today announced a collaboration with Checkpoint Therapeutics, Inc., for semi-mechanistic pharmacokinetic and pharmacodynamic (PK/PD) modeling in advanced metastatic solid tumors.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Xencor to perform semi-mechanistic PK/PD modeling to analyze Xencor's XmAb® IL15/IL15Rα-Fc program for the treatment of solid tumors. The collaboration will focus on developing a mathematical model relating XmAb®24306 modulated potency and extended half-life to observed pharmacokinetics and in vivo T-cell stimulation.

Monday, April 16, 2018

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling, simulation, and analysis to accelerate and de-risk drug research and development, today announced a collaboration with Pandion Therapeutics for semi-mechanistic pharmacokinetic and target occupancy (PK/TO) modeling in Autoimmune Disease.

Friday, February 2, 2018

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling, simulation, and analysis to drug research and development, today announced their newest Science Advisory Board member, Dhaval K. Shah, PhD.

Tuesday, January 16, 2018

The QSP Industry & Academia Symposium is a seminar series for presenting, learning, and discussing topics relevant to quantitative systems pharmacology (QSP).The goal of this event is to foster an active community of industry and academic participants interested in these topics, and create a forum for sharing of successes and challenges.

Register for the Symposium: www.appliedbiomath.com/QSPIAS

Tuesday, December 5, 2017

Applied BioMath® (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation at PepTalk: The Protein Science Week being held January 8-12, 2018 in San Diego, California.

Monday, December 4, 2017

Monday, November 13, 2017

Tuesday, November 7, 2017

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced that Dr. Douglas A. Lauffenburger has joined the speaker lineup for QSP Day 2018. The conference occurs Thursday, April 12, 2018 from 9:00 a.m. - 5:00 p.m. at the Samberg Conference Center, MIT Chang Building in Cambridge, MA.

Friday, October 27, 2017

[Webinar] Quantitative Modeling and Simulation Approaches: Driving Critical Decisions from Research through Clinical Trials
November 7, 2017 | 1 pm to 2 pm ET
Hosted by: Cambridge Healthtech Institute

Thursday, October 26, 2017

Monday, October 16, 2017

Monday, October 2, 2017

Monday, October 2, 2017

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation at the Antibody Engineering and Therapeutics Conference December 11-15, 2017 in San Diego, CA. John Burke, PhD, will present Model Aided Drug Invention (MADI) case studies on Thursday, December 14, 2017 at 12:00 p.m. In addition to speaking at the event, Applied BioMath is also participating as a scientific briefing sponsor.

Thursday, August 31, 2017

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation in FierceBiotech’s second Drug Development Forum occurring September 25-27, 2017 in Boston, MA. Applied BioMath will be a sponsor as well as presenter at the event.

Monday, July 31, 2017

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation in an upcoming quantitative systems pharmacology (QSP) event hosted by the Pharmaceutical and BioScience Society on September 29, 2017 in Boston, MA. Applied BioMath is the sole major sponsor of the day-long event as well as a presenter of two case studies in immuno-oncology and osteoarthritis.

Pages